2198 — China Sanjiang Fine Chemicals Co Balance Sheet
0.000.00%
- HK$3.63bn
- HK$15.79bn
- CNY19.59bn
- 54
- 94
- 94
- 96
Annual balance sheet for China Sanjiang Fine Chemicals Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,277 | 852 | 368 | 380 | 598 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 254 | 629 | 698 | 2,156 | 2,264 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,939 | 3,518 | 4,919 | 6,284 | 7,728 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 6,800 | 9,122 | 12,017 | 13,808 | 14,070 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 11,019 | 14,278 | 18,259 | 21,002 | 22,106 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 5,023 | 7,539 | 10,609 | 12,420 | 13,694 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6,306 | 9,612 | 13,961 | 16,621 | 17,194 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 4,713 | 4,666 | 4,298 | 4,381 | 4,912 |
| Total Liabilities & Shareholders' Equity | 11,019 | 14,278 | 18,259 | 21,002 | 22,106 |
| Total Common Shares Outstanding |